{"id":140751,"title":"Mammalian cell culture-based influenza vaccines: National Advisory Committee on Immunization Supplemental Statement, CCDR 46(10) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:16:47.509000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html?wbdisable=true","snippet":"Mammalian cell culture-based influenza vaccines: National Advisory Committee on Immunization Supplemental Statement, CCDR 46(10) - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu…","rawSnapshotUrl":"/api/snapshots/raw/140751","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141647/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html?wbdisable=true#ha_snapshot=140751","mimeType":"text/html","statusCode":200}